Poseida Therapeutics (PSTX)
(Delayed Data from NSDQ)
$2.13 USD
+0.08 (3.90%)
Updated Apr 26, 2024 04:00 PM ET
After-Market: $2.13 0.00 (0.00%) 7:58 PM ET
4-Sell of 5 4
F Value C Growth D Momentum F VGM
Key Expected Earnings Data
Report Date | Period Ending | Zacks Consensus Estimate | Earnings ESP |
---|---|---|---|
05/14/2024
Time: -- |
3/2024 | $-0.43 | 0.00% |
Earnings Summary
For their last quarter, Poseida Therapeutics (PSTX) reported earnings of -$0.27 per share, beating the Zacks Consensus Estimate of $-0.36 per share. This reflects a positive earnings surprise of 25.00%. Look out for PSTX's next earnings release expected on May 14, 2024. For the next earning release, we expect the company to report earnings of -$0.43 per share, reflecting a year-over-year increase of 4.44%.
Earnings History
Price & Consensus
Zacks News for PSTX
Poseida Therapeutics, Inc. (PSTX) Reports Q4 Loss, Tops Revenue Estimates
PSTX: What are Zacks experts saying now?
Zacks Private Portfolio Services